245 related articles for article (PubMed ID: 34735462)
1. Effect of PTPN22, FAS/FASL, IL2RA and CTLA4 genetic polymorphisms on the risk of developing alopecia areata: A systematic review of the literature and meta-analysis.
Gil-Quiñones SR; Sepúlveda-Pachón IT; Sánchez Vanegas G; Gutierrez-Castañeda LD
PLoS One; 2021; 16(11):e0258499. PubMed ID: 34735462
[TBL] [Abstract][Full Text] [Related]
2. Genetic variant association of PTPN22, CTLA4, IL2RA, as well as HLA frequencies in susceptibility to alopecia areata.
Moravvej H; Tabatabaei-Panah PS; Abgoon R; Khaksar L; Sokhandan M; Tarshaei S; Ghaderian SMH; Ludwig RJ; Akbarzadeh R
Immunol Invest; 2018 Oct; 47(7):666-679. PubMed ID: 29979892
[TBL] [Abstract][Full Text] [Related]
3. The association between rs2476601 polymorphism in PTPN22 gene and risk of alopecia areata: A meta-analysis of case-control studies.
Lei ZX; Chen WJ; Liang JQ; Wang YJ; Jin L; Xu C; Kang XJ
Medicine (Baltimore); 2019 May; 98(20):e15448. PubMed ID: 31096440
[TBL] [Abstract][Full Text] [Related]
4. Overlapping and Distinct
Tabatabaei-Panah PS; Moravvej H; Arian S; Fereidonpour I; Behravesh N; Atoon A; Ludwig RJ; Akbarzadeh R
Immunol Invest; 2020 Feb; 49(1-2):204-214. PubMed ID: 31741398
[TBL] [Abstract][Full Text] [Related]
5. The association of PTPN22 (rs2476601) and IL2RA (rs11594656) polymorphisms with T1D in Egyptian children.
Abdelrahman HM; Sherief LM; Abd Elrahman DM; Alghobashy A; Elsaadani HF; Mohamed RH
Hum Immunol; 2016 Aug; 77(8):682-686. PubMed ID: 27288719
[TBL] [Abstract][Full Text] [Related]
6. The association of PTPN22 rs2476601 polymorphism and CTLA-4 rs231775 polymorphism with LADA risks: a systematic review and meta-analysis.
Dong F; Yang G; Pan HW; Huang WH; Jing LP; Liang WK; Zhang N; Zhang BH; Wang M; Liu Y; Zhang LJ; Zhang SH; Li H; Chen C; Nie LH; Jing CX
Acta Diabetol; 2014 Oct; 51(5):691-703. PubMed ID: 25005490
[TBL] [Abstract][Full Text] [Related]
7. Functional polymorphisms of the FAS/FASLG genes are associated with risk of alopecia areata in a Chinese population: a case-control analysis.
Fan X; Shangguan L; Li M; Li CY; Liu B
Br J Dermatol; 2010 Aug; 163(2):340-4. PubMed ID: 20394629
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic T-lymphocyte antigen 4 (CTLA4) +49AG and CT60 gene polymorphisms in Alopecia Areata: a case-control association study in the Italian population.
Megiorni F; Mora B; Maxia C; Gerardi M; Pizzuti A; Rossi A
Arch Dermatol Res; 2013 Sep; 305(7):665-70. PubMed ID: 23567921
[TBL] [Abstract][Full Text] [Related]
9. Association analysis of PTPN22, CTLA4 and IFIH1 genes with type 1 diabetes in Colombian families.
Rodríguez A; Alfaro JM; Balthazar V; Pineda Trujillo N
J Diabetes; 2015 May; 7(3):402-10. PubMed ID: 25042601
[TBL] [Abstract][Full Text] [Related]
10. Association of variants in PTPN22, CTLA-4, IL2-RA, and INS genes with type 1 diabetes in Emiratis.
Sharma C; R Ali B; Osman W; Afandi B; Aburawi EH; Beshyah SA; Al-Mahayri Z; Al-Rifai RH; Al Yafei Z; ElGhazali G; Alkaabi J
Ann Hum Genet; 2021 Mar; 85(2):48-57. PubMed ID: 32970831
[TBL] [Abstract][Full Text] [Related]
11. PTPN22 gene polymorphism in Egyptian alopecia areata patients and its impact on response to diphencyprone immunotherapy.
El-Zawahry BM; Azzam OA; Zaki NS; Abdel-Raheem HM; Bassiouny DA; Khorshied MM
Gene; 2013 Jul; 523(2):147-51. PubMed ID: 23570882
[TBL] [Abstract][Full Text] [Related]
12. Association of PTPN22 rs2476601 and STAT4 rs7574865 polymorphisms with rheumatoid arthritis: A meta-analysis update.
Elshazli R; Settin A
Immunobiology; 2015 Aug; 220(8):1012-24. PubMed ID: 25963842
[TBL] [Abstract][Full Text] [Related]
13. Association of CTLA-4 gene polymorphisms and alopecia areata: a systematic review and meta-analysis.
Zhou B; Chen M; Shang S; Zhao J
Biomarkers; 2022 Jun; 27(4):338-348. PubMed ID: 35254172
[TBL] [Abstract][Full Text] [Related]
14. PTPN22 profile indicates a novel risk group in Alopecia areata.
Bhanusali DG; Sachdev A; Olson MA; Gerlach JA; Sinha AA
Hum Immunol; 2014 Jan; 75(1):81-7. PubMed ID: 24055692
[TBL] [Abstract][Full Text] [Related]
15. The CTLA-4 +49 A/G, CT60 A/G and PTPN22 1858 C/T polymorphisms and susceptibility to vitiligo: a meta-analysis.
Song GG; Kim JH; Lee YH
Mol Biol Rep; 2013 Apr; 40(4):2985-93. PubMed ID: 23264102
[TBL] [Abstract][Full Text] [Related]
16. Associations of single nucleotide polymorphisms of PTPN22 and Ctla4 genes with the risk of allergic rhinitis in a Chinese Han population.
Ke X; Song S; Wang X; Shen Y; Kang H; Hong S
Hum Immunol; 2017 Feb; 78(2):227-231. PubMed ID: 27888068
[TBL] [Abstract][Full Text] [Related]
17. Autoimmunity-Related Risk Variants in PTPN22 and CTLA4 Are Associated With ME/CFS With Infectious Onset.
Steiner S; Becker SC; Hartwig J; Sotzny F; Lorenz S; Bauer S; Löbel M; Stittrich AB; Grabowski P; Scheibenbogen C
Front Immunol; 2020; 11():578. PubMed ID: 32328064
[TBL] [Abstract][Full Text] [Related]
18. Identification of susceptibility SNPs in CTLA-4 and PTPN22 for scleritis in Han Chinese.
Li F; Ma X; Du L; Shi L; Cao Q; Li N; Pang T; Liu Y; Kijlstra A; Yang P
Clin Exp Immunol; 2019 Aug; 197(2):230-236. PubMed ID: 30921471
[TBL] [Abstract][Full Text] [Related]
19. Relation of the Fas and FasL gene polymorphisms with susceptibility to and severity of rheumatoid arthritis.
Yıldır S; Sezgin M; Barlas IÖ; Türköz G; Ankaralı HÇ; Şahin G; Erdal ME
Rheumatol Int; 2013 Oct; 33(10):2637-45. PubMed ID: 23749041
[TBL] [Abstract][Full Text] [Related]
20. PTPN22 gene polymorphism and susceptibility to rheumatoid arthritis (RA): Updated systematic review and meta-analysis.
Abbasifard M; Imani D; Bagheri-Hosseinabadi Z
J Gene Med; 2020 Sep; 22(9):e3204. PubMed ID: 32333475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
